Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) in Preclinical Studies of Antivascular Treatments
Antivascular treatments can either be antiangiogenic or targeting established tumour vasculature. These treatments affect the tumour microvasculature and microenvironment but may not change clinical measures like tumour volume and growth. In research on antivascular treatments, information on the tu...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2012-11-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | http://www.mdpi.com/1999-4923/4/4/563 |
id |
doaj-de8ddbd803cb462ebedb858209f6ca38 |
---|---|
record_format |
Article |
spelling |
doaj-de8ddbd803cb462ebedb858209f6ca382020-11-24T21:03:59ZengMDPI AGPharmaceutics1999-49232012-11-014456358910.3390/pharmaceutics4040563Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) in Preclinical Studies of Antivascular TreatmentsMichael R. HorsmanThomas WittenbornThomas NielsenAntivascular treatments can either be antiangiogenic or targeting established tumour vasculature. These treatments affect the tumour microvasculature and microenvironment but may not change clinical measures like tumour volume and growth. In research on antivascular treatments, information on the tumour vasculature is therefore essential. Preclinical research is often used for optimization of antivascular drugs alone or in combined treatments. Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) is an in vivo imaging method providing vascular information, which has become an important tool in both preclinical and clinical research. This review discusses common DCE-MRI imaging protocols and analysis methods and provides an overview of preclinical research on antivascular treatments utilizing DCE-MRI.http://www.mdpi.com/1999-4923/4/4/563DCE-MRIangiogenesis inhibitorsvascular disrupting agentspreclinical studies |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Michael R. Horsman Thomas Wittenborn Thomas Nielsen |
spellingShingle |
Michael R. Horsman Thomas Wittenborn Thomas Nielsen Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) in Preclinical Studies of Antivascular Treatments Pharmaceutics DCE-MRI angiogenesis inhibitors vascular disrupting agents preclinical studies |
author_facet |
Michael R. Horsman Thomas Wittenborn Thomas Nielsen |
author_sort |
Michael R. Horsman |
title |
Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) in Preclinical Studies of Antivascular Treatments |
title_short |
Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) in Preclinical Studies of Antivascular Treatments |
title_full |
Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) in Preclinical Studies of Antivascular Treatments |
title_fullStr |
Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) in Preclinical Studies of Antivascular Treatments |
title_full_unstemmed |
Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) in Preclinical Studies of Antivascular Treatments |
title_sort |
dynamic contrast-enhanced magnetic resonance imaging (dce-mri) in preclinical studies of antivascular treatments |
publisher |
MDPI AG |
series |
Pharmaceutics |
issn |
1999-4923 |
publishDate |
2012-11-01 |
description |
Antivascular treatments can either be antiangiogenic or targeting established tumour vasculature. These treatments affect the tumour microvasculature and microenvironment but may not change clinical measures like tumour volume and growth. In research on antivascular treatments, information on the tumour vasculature is therefore essential. Preclinical research is often used for optimization of antivascular drugs alone or in combined treatments. Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) is an in vivo imaging method providing vascular information, which has become an important tool in both preclinical and clinical research. This review discusses common DCE-MRI imaging protocols and analysis methods and provides an overview of preclinical research on antivascular treatments utilizing DCE-MRI. |
topic |
DCE-MRI angiogenesis inhibitors vascular disrupting agents preclinical studies |
url |
http://www.mdpi.com/1999-4923/4/4/563 |
work_keys_str_mv |
AT michaelrhorsman dynamiccontrastenhancedmagneticresonanceimagingdcemriinpreclinicalstudiesofantivasculartreatments AT thomaswittenborn dynamiccontrastenhancedmagneticresonanceimagingdcemriinpreclinicalstudiesofantivasculartreatments AT thomasnielsen dynamiccontrastenhancedmagneticresonanceimagingdcemriinpreclinicalstudiesofantivasculartreatments |
_version_ |
1716772421655068672 |